Certain foods and nutrients were found to influence the risk of developing liver cancer. For example, aflatoxins (toxins from ...

Over 80% of hepatocellular carcinoma (HCC) – the third-leading cause of cancer deaths globally – emerges from advanced liver fibrosis or cirrhosis. A comprehensive review in Hepatology International ...

This review explores the dynamic landscape of hepatocellular carcinoma (HCC) treatment, emphasizing on recent developments across various stages and therapeutic approaches. Although curative ...

More than 500,000 annual liver cancer diagnoses could be prevented with global interventions aimed at reducing viral hepatitis B and C, alcohol consumption and a disease strongly associated with ...

A new study has established that the follow-up of the fatty liver index (FLI), both baseline and longitudinally, is an ...

Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking preclinical data for the treatment ...

A new Lancet study warns liver cancer cases could nearly double by 2050, if no action is taken. The authors emphasise ...

Imagine a future where the global incident cases of liver cancer almost doubles, rising from 870 000 cases in 2022 to over 1·5 million in 2050. This scenario, and all the attendant harms to health and ...

“There are a lot of treatment options depending on how bad your liver disease is, how many cancers in the liver you have, how ...

Hepatocellular carcinoma (HCC) is the sixth most common cancer and the fourth most common cause of cancer-related death worldwide. 1 In 2017, there were an estimated 953,000 incident cases of liver ...